Vimarsana
Biggest News Aggregation in the World

600e News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 600e. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 600e Today - Breaking & Trending Today

Emergency crews responding to serious crash in Hamlet - Vimarsana News

Emergency crews responding to serious crash in Hamlet

According to the Starke County Sheriff’s Office, it happened in the area of U.S. 30 and 600 E.

Source: wndu.com
Novartis Pharma AG: Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer - Vimarsana News

Novartis Pharma AG: Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer

New approval based on TADPOLE trial showing overall response rate (ORR) of 47% and median progression-free survival (mPFS) of 20.1 months for Tafinlar + Mekinist compared to 11% ORR and 7.4 months mPFS

Novartis Pharma AG: Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors - Vimarsana News

Novartis Pharma AG: Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors

Tafinlar + Mekinist, the worldwide targeted therapy leader in BRAF/MEK-inhibition, is the first and only therapy to be approved with a tumor-agnostic indication for adult and pediatric patients with solid

Personalised medicine: Australia aims to end childhood cancer deaths - Vimarsana News

Personalised medicine: Australia aims to end childhood cancer deaths

An Australian plan to eliminate childhood cancer deaths using personalised medicine will be made available to all Australian children with the condition from 2023